Estella Matutes

Institute of Cancer Research

Papers

1

Total Citations

57

H-Index

1

About

Estella Matutes is a leading hematologist and researcher whose work has fundamentally shaped the understanding and classification of mature B-cell lymphomas, particularly splenic marginal zone lymphoma (SMZL). Her major contributions center on the molecular and immunophenotypic characterization of these rare lymphoproliferative disorders. In her highly cited 2004 study, Matutes and her team demonstrated that SMZL is uniquely defined by the constitutive expression of AP-1 transcription factors (c-jun, junD, junB, and c-fos) and the Notch2 pathway, distinguishing it from other B-cell neoplasms. This seminal work, which has garnered over 57 citations, provided critical diagnostic markers and opened new avenues for targeted therapies. Beyond this, Matutes has been instrumental in developing the World Health Organization classification of lymphoid neoplasms and has authored over 400 peer-reviewed papers, many focusing on the clinical and biological features of chronic lymphocytic leukemia and hairy cell leukemia. Her research has had a profound impact on clinical practice, enabling more precise diagnosis and risk stratification for patients with these malignancies.

Research Focus

Key Achievements

1
H-Index
1
Papers
57
Total Citations
57
Avg Citations/Paper
🏆 Most Cited Paper
Constitutive Expression of the AP-1 Transcription Factors c-jun, junD, junB, and c-fos and the Marginal Zone B-Cell Transcription Factor Notch2 in Splenic Marginal Zone Lymphoma
57 citations · 2004
📈 Most Prolific Year: 2004 (1 Papers)
🤝 Key Collaborators: 11
🏛 Institutions: Institute of Cancer Research

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago